small molecule glp 1 agonist Drug Hunter's 2023 Patent Review of GLP-1R Agonists | Drug Hunter posted on the topic Small-molecule agonists activate the Ga
Description
More recent data tells a different story
S1542356524004531
Should metformin remain the firstline therapy for treatment of type 2 diabetes
In November 2023, tirzepatide was also approved for chronic weight management in adults with obesity or overweight and at least one weight-related comorbidity
The future will usher in multiple new ways of delivering GLP-1 medicines, and activating GLP-1R signaling pathways, promising improved efficacy/convenience
Hospital pharmacies stay stable, dispensing mainly to inpatients or clinic-based diabetes programs
